COSCIENS Biopharma Total Assets

COSCIENS Biopharma's total assets stands at $28M as of June 2025. That compares with $50M in the prior-year period — down 44.9% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

COSCIENS Biopharma reported $28M in total assets versus $50M a year earlier — a 44.9% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $50M in the prior-year period — down 44.9% year over year. Sustained growth in total assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how COSCIENS Biopharma's total assets evolved across reporting periods, while the comparison chart places CSCI next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.